Hb Wealth Management, LLC Astrazeneca PLC Transaction History
Hb Wealth Management, LLC
- $14.5 Billion
- Q3 2025
A detailed history of Hb Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hb Wealth Management, LLC holds 47,558 shares of AZN stock, worth $4.25 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
47,558
Previous 27,650
72.0%
Holding current value
$4.25 Million
Previous $1.93 Million
88.82%
% of portfolio
0.03%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...